Vorasidenib
Commons · Question 86308 · Tabled 29 Oct 2025 · Department of Health and Social Care · Official record
Answered 6 Nov 2025
Question
Asked by Daisy Cooper
To ask the Secretary of State for Health and Social Care, what discussions his Department has had discussions with (a) NICE and (b) Servier on the barriers to approving Vorasidenib for use by the NHS for the treatment of low glade glioma.
Answer
Answered by Zubir Ahmed, 6 Nov 2025
Department officials regularly speak with colleagues in the National Institute for Health and Care Excellence (NICE) to discuss a range of issues, including the status of individual appraisals. As NICE is an independent body, it would not be appropriate f...